• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型三唑类阿片受体拮抗剂的发现

Discovery of novel triazole-based opioid receptor antagonists.

作者信息

Zhang Qiang, Keenan Susan M, Peng Youyi, Nair Anil C, Yu Seong Jae, Howells Richard D, Welsh William J

机构信息

Department of Pharmacology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey and UMDNJ Informatics Institute, Piscataway, New Jersey 08854, USA.

出版信息

J Med Chem. 2006 Jul 13;49(14):4044-7. doi: 10.1021/jm0601250.

DOI:10.1021/jm0601250
PMID:16821764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2693423/
Abstract

We report the computer-aided design, chemical synthesis, and biological evaluation of a novel family of delta opioid receptor (DOR) antagonists containing a 1,2,4-triazole core structure that are structurally distinct from other known opioid receptor active ligands. Among those delta antagonists sharing this core structure, 8 exhibited strong binding affinity (K(i) = 50 nM) for the DOR and appreciable selectivity for delta over mu and kappa opioid receptors (delta/mu = 80; delta/kappa > 200).

摘要

我们报告了一类新型δ阿片受体(DOR)拮抗剂的计算机辅助设计、化学合成及生物学评价,这类拮抗剂含有1,2,4-三唑核心结构,在结构上与其他已知的阿片受体活性配体不同。在具有这种核心结构的δ拮抗剂中,有8种对DOR表现出强结合亲和力(K(i)=50 nM),并且对δ受体相对于μ和κ阿片受体具有显著的选择性(δ/μ = 80;δ/κ>200)。

相似文献

1
Discovery of novel triazole-based opioid receptor antagonists.新型三唑类阿片受体拮抗剂的发现
J Med Chem. 2006 Jul 13;49(14):4044-7. doi: 10.1021/jm0601250.
2
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.生物可利用的、具有混合效应的μ-阿片受体(MOR)激动剂/δ-阿片受体(DOR)拮抗剂的进一步优化与评估:平衡MOR和DOR亲和力
J Med Chem. 2015 Nov 25;58(22):8952-69. doi: 10.1021/acs.jmedchem.5b01270. Epub 2015 Nov 13.
3
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.阿片受体的新型配体:5'-芳基和5'-杂芳基17-环丙基甲基-4,5α-环氧吡啶并[2',3':6,7]吗啡喃的合成及其构效关系
Bioorg Med Chem. 2003 Sep 1;11(18):4143-54. doi: 10.1016/s0968-0896(03)00432-2.
4
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.去甲羟吗啡吲哚、17-取代-6,7-脱氢-4,5α-环氧-3,14-二羟基-6,7:2',3'-吲哚吗啡喃中的N-烷基和N-烯基取代基对阿片受体亲和力、选择性和效力的影响。
J Med Chem. 2001 Apr 26;44(9):1471-4. doi: 10.1021/jm000511w.
5
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.吲哚苯部分被取代的纳曲吲哚类似物的合成、阿片受体结合及生物活性测定。
J Med Chem. 1998 Jul 16;41(15):2872-81. doi: 10.1021/jm980083i.
6
Biaryl piperidines as potent and selective delta opioid receptor ligands.联苯哌啶类化合物作为强效和选择性的 δ 阿片受体配体。
Bioorg Med Chem Lett. 2010 Jan 15;20(2):503-7. doi: 10.1016/j.bmcl.2009.11.113. Epub 2009 Nov 26.
7
The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores.克隆的μ、δ和κ受体及其内源性配体:两个阿片肽识别核心的证据。
Brain Res. 1995 Nov 27;700(1-2):89-98. doi: 10.1016/0006-8993(95)00928-j.
8
Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.首个对μ、δ、κ和孤啡肽阿片受体具有纳摩尔亲和力的小分子阿片类全拮抗剂的发现。
ACS Chem Neurosci. 2015 Apr 15;6(4):646-57. doi: 10.1021/cn500367b. Epub 2015 Feb 18.
9
Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.通过阿片受体的定点诱变研究羟吗啡酮和纳曲酮衍生配体的选择性:探索“地址”识别位点。
J Med Chem. 2001 Mar 15;44(6):857-62. doi: 10.1021/jm000381r.
10
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.6α-和6β-N-杂环取代纳曲胺衍生物作为μ阿片受体选择性拮抗剂的设计、合成及生物学评价
J Med Chem. 2009 Mar 12;52(5):1416-27. doi: 10.1021/jm801272c.

引用本文的文献

1
Triazole-Bridged Zinc Dinuclear Complexes: Mechanochemical Synthesis, Crystal Structure, and Biological Activity.三唑桥联锌双核配合物:机械化学合成、晶体结构及生物活性
ACS Omega. 2022 Nov 4;7(45):40860-40868. doi: 10.1021/acsomega.2c03715. eCollection 2022 Nov 15.
2
Identification of an irreversible PPARγ antagonist with potent anticancer activity.鉴定具有强大抗癌活性的不可逆 PPARγ 拮抗剂。
Pharmacol Res Perspect. 2020 Dec;8(6):e00693. doi: 10.1002/prp2.693.
3
The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments.取代基在去甲氢吗啡酮 - 苯乙胺部分的有趣影响:一组“尾巴摇狗”实验中的双功能阿片类药物。
Molecules. 2020 Jun 6;25(11):2640. doi: 10.3390/molecules25112640.
4
Synthesis and spectroscopic properties of new azo dyes derived from 3-ethylthio-5-cyanomethyl-4-phenyl-1,2,4-triazole.源自3-乙硫基-5-氰甲基-4-苯基-1,2,4-三唑的新型偶氮染料的合成及光谱性质
Molecules. 2014 Mar 7;19(3):2993-3003. doi: 10.3390/molecules19032993.
5
Highly potent triazole-based tubulin polymerization inhibitors.高效的基于三唑的微管蛋白聚合抑制剂。
J Med Chem. 2007 Feb 22;50(4):749-54. doi: 10.1021/jm061142s. Epub 2007 Jan 24.
6
Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach.使用一种新型虚拟筛选方法鉴定先前未被识别的抗雌激素化学物质。
Chem Res Toxicol. 2006 Dec;19(12):1595-601. doi: 10.1021/tx060218k.

本文引用的文献

1
Modern Variants of the Mannich Reaction.曼尼希反应的现代变体
Angew Chem Int Ed Engl. 1998 May 4;37(8):1044-1070. doi: 10.1002/(SICI)1521-3773(19980504)37:8<1044::AID-ANIE1044>3.0.CO;2-E.
2
Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.内源性脑啡肽对情绪相关行为的生理控制主要涉及δ阿片受体。
Neuroscience. 2005;135(2):305-13. doi: 10.1016/j.neuroscience.2005.06.025.
3
3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs.δ阿片受体激动剂SNC80及其类似物的3D-QSAR比较分子场分析
J Mol Graph Model. 2005 Sep;24(1):25-33. doi: 10.1016/j.jmgm.2005.05.001.
4
Opioids: old drugs for potential new applications.阿片类药物:具有潜在新用途的老药。
Curr Pharm Des. 2005;11(10):1343-50. doi: 10.2174/1381612053507459.
5
3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.阿片受体拮抗剂的3D-QSAR比较分子场分析:整合来自不同研究的数据
J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e.
6
Enrichment of ligands for the serotonin receptor using the Shape Signatures approach.
J Chem Inf Model. 2005 Jan-Feb;45(1):49-57. doi: 10.1021/ci049746x.
7
Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].在源自纳洛酮、羟吗啡酮和氢吗啡酮[纠正为氢吗啡酮]的吡啶吗啡喃类化合物中鉴定具有混合μ激动剂/δ拮抗剂活性的阿片样物质配体。
J Med Chem. 2004 Mar 11;47(6):1400-12. doi: 10.1021/jm030311v.
8
Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design.形状特征:基于计算机辅助配体和受体的药物设计新方法。
J Med Chem. 2003 Dec 18;46(26):5674-90. doi: 10.1021/jm030242k.
9
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.δ-阿片受体激动剂(+)BW373U86调节大鼠脑源性神经营养因子(BDNF)mRNA的表达。
Neuropsychopharmacology. 2004 Apr;29(4):649-59. doi: 10.1038/sj.npp.1300345.
10
Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.14-烷氧基吗啡喃的合成及生物学评价。18. 具有意外激动剂特性的N-取代14-苯基丙氧基吗啡喃-6-酮:拓展常见构效关系的范围
J Med Chem. 2003 Apr 24;46(9):1758-63. doi: 10.1021/jm021118o.